Brief: Aequus gets approval from Health Canada to initiate proof of concept clinical trial of anti-nausea patch
05/07/2017 14:00
July 5 (Reuters) - Aequus Pharmaceuticals Inc AQS.V :
* Aequus receives approval from Health Canada to initiate
proof of concept clinical trial of anti-nausea patch
* Aequus Pharmaceuticals Inc - preparing for a
pre-investigational new drug (pre-IND) meeting with US Food And
Drug Administration (FDA)
Source text for Eikon: ID:nMKWNG1RJa
Further company coverage: AQS.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange